HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conservative management of asymptomatic popliteal aneurysm.

Abstract
Historical review shows that the treatment of popliteal aneurysm has developed by trial and error and there is disagreement about the proper management of the symptomless patient. In 1981 a policy of conservative management for asymptomatic popliteal aneurysm was adopted in this unit. Since that time we have also managed nine patients with thrombosed popliteal aneurysms by arteriography and low-dose intra-arterial streptokinase. Six patients treated within 72 h of occlusion achieved significant (70-100 per cent) lysis, but streptokinase was ineffective in those treated 10 or more days after the thrombosis. Of the six patients with significant lysis, three were treated by elective reconstruction and two by anticoagulation. One patient who had significant lysis died. Vascular patency of all five successfully treated limbs was maintained and no limb loss occurred in those who presented late and failed to achieve significant lysis. These results reinforce the view that thrombolysis is the treatment of choice for thrombosed popliteal aneurysms. The low complication rate for asymptomatic popliteal aneurysms and the advent of safe, effective thrombolysis indicate that operation for symptomless popliteal aneurysm is no longer required.
AuthorsR C Bowyer, S J Cawthorn, W J Walker, A E Giddings
JournalThe British journal of surgery (Br J Surg) Vol. 77 Issue 10 Pg. 1132-5 (Oct 1990) ISSN: 0007-1323 [Print] England
PMID2224462 (Publication Type: Journal Article)
Chemical References
  • Streptokinase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aneurysm (complications, surgery)
  • Humans
  • Middle Aged
  • Popliteal Artery (diagnostic imaging, surgery)
  • Radiography
  • Streptokinase (administration & dosage, therapeutic use)
  • Thromboembolism (drug therapy, etiology)
  • Thrombolytic Therapy
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: